Marie Laurencin

Statistics

Publications

Citations

361

H-Index

Active since

2016

Affiliations

Novartis (Switzerland)(Current)

University of Leicester

Marie Laurencin is an author at Novartis (Switzerland) specializing in chronic obstructive pulmonary disease, asthma management, and placebo-controlled efficacy assessment.

Publications per year

2016–2016

Publications

Fevipiprant, a prostaglandin D 2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled trial

Sherif Gonem, Rachid Berair, Amisha Singapuri et al. · The Lancet Respiratory Medicine · 2016 · 248 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +8

Relationship between lung function and quantitative computed tomographic parameters of airway remodeling, air trapping, and emphysema in patients with asthma and chronic obstructive pulmonary disease: A single-center study

Ruth Hartley, Bethan L. Barker, Chris Newby et al. · Journal of Allergy and Clinical Immunology · 2016 · 113 citations · Full text

Medicine, Clinical Sciences, Radiology +17

1–2 of 2